JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 80 filers reported holding JOUNCE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $102,000 | -19.7% | 15,009 | +21.7% | 0.01% | -22.2% |
| Q1 2021 | $127,000 | -56.8% | 12,335 | -80.1% | 0.01% | -60.9% |
| Q1 2020 | $294,000 | +153.4% | 61,968 | +367.0% | 0.02% | +228.6% |
| Q4 2019 | $116,000 | +28.9% | 13,268 | -50.7% | 0.01% | +40.0% |
| Q3 2019 | $90,000 | -40.8% | 26,900 | -12.4% | 0.01% | -44.4% |
| Q2 2019 | $152,000 | -43.1% | 30,700 | -28.8% | 0.01% | -40.0% |
| Q1 2019 | $267,000 | – | 43,112 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BML Capital Management, LLC | 1,087,961 | $2,012,728 | 1.74% |
| Opaleye Management Inc. | 2,880,000 | $5,328,000 | 1.60% |
| TANG CAPITAL MANAGEMENT LLC | 5,300,087 | $9,805,161 | 1.46% |
| Ardent Capital Management, Inc. | 923,463 | $1,708,407 | 1.23% |
| Beryl Capital Management LLC | 610,831 | $1,130,037 | 0.89% |
| Arena Investors LP | 610,639 | $1,129,682 | 0.88% |
| Omega Fund Management, LLC | 275,513 | $509,699 | 0.33% |
| Deep Track Capital, LP | 4,259,653 | $7,880,358 | 0.32% |
| PenderFund Capital Management Ltd. | 246,310 | $616 | 0.19% |
| GABELLI & Co INVESTMENT ADVISERS, INC. | 425,100 | $786,435 | 0.15% |